S. Yoshihara

发表

Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period

H. Tamaki, T. Soma, H. Ogawa, 2016, The Journal of Immunology.

Peritransplantation Period thea Negative Regulator of Dendritic Cells in Regulatory T Cells Act as + CD 4 + Host Foxp 3

H. Tamaki, T. Soma, H. Ogawa, 2015 .

A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors.

Y. Kanda, M. Kami, K. Mitani, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Modeling Human Leukemia Immunotherapy in Humanized Mice

Wei Li, M. Sykes, Yong-Guang Yang, 2016, EBioMedicine.

Gender differences in health‐related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation

K. Domen, H. Ogawa, S. Morishita, 2013, Psycho-oncology.

Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation

K. Domen, H. Ogawa, S. Morishita, 2012, Supportive Care in Cancer.

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

T. Kyo, H. Dohy, I. Kawase, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice

M. Sykes, Yong-Guang Yang, N. Danzl, 2019, Front. Immunol..

Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia

S. Miyano, Y. Shiraishi, K. Chiba, 2021, Nature Communications.

Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.

S. Mineishi, G. Yanik, S. Yoshihara, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma

S. Mineishi, Y. Kanda, M. Kami, 2003, Bone Marrow Transplantation.

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP

K. Kitajima, K. Yamakado, H. Tamaki, 2019, Oncotarget.

Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum

K. Ohta, J. Kanda, M. Hino, 2021, EJHaem.

Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

S. Mineishi, U. Tateishi, H. Kunitoh, 2005, Bone Marrow Transplantation.

Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?

K. Kitajima, K. Yamakado, T. Kashiwagi, 2019, European Radiology.

Frequency of CD4+FOXP3+ regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD

H. Tamaki, T. Fujioka, T. Soma, 2013, Bone Marrow Transplantation.

Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor

S. Kimura, K. Kojima, S. Yoshihara, 2020, International Journal of Hematology.

The role of HLA antibodies in allogeneic SCT: is the ‘type-and-screen’ strategy necessary not only for blood type but also for HLA?

H. Ogawa, S. Yoshihara, K. Taniguchi, 2012, Bone Marrow Transplantation.

Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome

H. Tamaki, T. Fujioka, T. Soma, 2012, Bone Marrow Transplantation.

Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma.

M. Okada, S. Yoshihara, Y. Fujimori, 2021, Hematology.

Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapy

M. Asakura, H. Tamaki, M. Ishihara, 2022, Leukemia research reports.

Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene

H. Tamaki, T. Soma, H. Ogawa, 2011, International journal of hematology.

Final 3‐year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second‐line Treatment

J. Sakamoto, M. Hino, S. Kimura, 2018, Clinical lymphoma, myeloma & leukemia.

Early prediction of extramedullary relapse of leukemia following allogeneic stem cell transplantation using the WT1 transcript assay

H. Tamaki, M. Kawakami, T. Fujioka, 2006 .

Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies

I. Kawase, N. Hosen, Y. Oji, 2005, Leukemia.

Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.

H. Tamaki, T. Fujioka, T. Soma, 2011, Experimental hematology.

Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.

I. Kawase, K. Aozasa, M. Kawakami, 2008, Experimental hematology.

Aldehyde dehydrogenase activity in cryopreserved cord blood cells for quality assessment prior to transplantation.

S. Yoshihara, Y. Fujimori, S. Kai, 2018, Molecular medicine reports.

Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution

S. Mineishi, Y. Kanda, H. Wakasugi, 2003, Transplantation.

A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced‐intensity conditioning

H. Ogawa, Y. Najima, K. Ikegame, 2018, European journal of haematology.

Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study.

H. Tamaki, T. Soma, H. Ogawa, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy

T. Fujioka, H. Ogawa, T. Tanizawa, 2012, Transfusion.

Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning

H. Tamaki, T. Fujioka, T. Soma, 2012, Bone Marrow Transplantation.

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis

K. Ohta, J. Kanda, M. Hino, 2022, Therapeutic advances in hematology.

Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells

H. Okamura, H. Tamaki, T. Fujioka, 2010, International journal of hematology.

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

I. Kawase, K. Aozasa, Y. Oji, 2004, Cancer Immunology, Immunotherapy.

Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis

K. Ohta, J. Kanda, M. Hino, 2021, European journal of haematology.

Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia

H. Tamaki, K. Yamahara, S. Higasa, 2021, Transfusion medicine.

WT1 Peptide‐Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases

I. Kawase, K. Aozasa, N. Hosen, 2004, Microbiology and immunology.

Update on granulocyte transfusions: accumulation of promising data, but still lack of decisive evidence

S. Yoshihara, Y. Fujimori, Junko Ikemoto, 2016, Current opinion in hematology.

Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide

K. Ohta, J. Kanda, T. Matsui, 2022, Therapeutic advances in hematology.

T‐cell lymphoma, B‐cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone

S. Hirota, S. Ogawa, Y. Nannya, 2021, EJHaem.

Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: Possible association with nelarabine

M. Kawakami, H. Ogawa, K. Ikegame, 2013, American journal of hematology.

Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse.

H. Ogawa, S. Yoshihara, T. Ando, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT

H. Tamaki, T. Fujioka, T. Soma, 2012, Bone Marrow Transplantation.

Low incidence of HHV‐6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft‐vs‐host disease prophylaxis compared with cord blood transplantation

H. Tamaki, T. Fujioka, T. Soma, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial

H. Tamaki, T. Soma, H. Ogawa, 2019, BMJ Open.

Seroprevalence and field isolation of bovine immunodeficiency virus.

K. Ohashi, C. Sugimoto, M. Onuma, 1998, The Journal of veterinary medical science.

Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor

R. Suzuki, H. Ogawa, H. Sakamaki, 2010, International journal of hematology.

Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain

K. Akashi, K. Takenaka, H. Kishima, 2022, Science Translational Medicine.

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38− cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells

I. Kawase, N. Hosen, Y. Sonoda, 2004, Leukemia.

Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation

H. Tamaki, T. Fujioka, T. Soma, 2012, Annals of Hematology.

Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.

I. Kawase, H. Tamaki, M. Kawakami, 2008, Experimental hematology.

Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.

I. Kawase, M. Kawakami, T. Fujioka, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A case of immune recovery vitritis induced by donor leukocyte infusion for the treatment of cytomegalovirus retinitis

I. Kawase, M. Kawakami, Y. Oka, 2005, European journal of haematology.

Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation

I. Kawase, M. Kawakami, Y. Oka, 2004, Transplantation.

Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients

H. Tamaki, T. Fujioka, T. Soma, 2012, International Journal of Hematology.

Expression of activated integrin β7 in multiple myeloma patients

I. Hanamura, S. Iida, M. Kizaki, 2021, International Journal of Hematology.

Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan.

Y. Kanda, Y. Kodera, H. Tamaki, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient

M. Kawakami, T. Fujioka, H. Ogawa, 2006, Bone Marrow Transplantation.

Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation

H. Tamaki, H. Ogawa, J. Nakata, 2011, International journal of hematology.

Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study

H. Tamaki, H. Ogawa, Azusa Mayumi, 2020, Bone Marrow Transplantation.

Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning

H. Tamaki, T. Soma, H. Ogawa, 2014, International Journal of Hematology.

Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria

T. Matsui, H. Ogawa, K. Ikegame, 2011, International journal of hematology.

Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors

H. Tamaki, T. Fujioka, T. Soma, 2012, Bone Marrow Transplantation.

Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan

T. Matsui, Y. Kodera, R. Suzuki, 2011, International journal of hematology.

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

H. Tamaki, T. Fujioka, T. Soma, 2011 .

Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation

T. Kijima, H. Tamaki, H. Ogawa, 2022, International Journal of Hematology.

Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation

H. Tamaki, T. Fujioka, H. Ogawa, 2012, European journal of haematology.

Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation

H. Tamaki, T. Fujioka, T. Soma, 2015, Annals of Hematology.

Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen.

I. Kawase, H. Ogawa, H. Sugiyama, 2003, Haematologica.

Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation.

H. Tamaki, H. Ogawa, J. Nakata, 2011, Leukemia research.

Spousal hematopoietic stem cell transplantation

H. Tamaki, T. Soma, H. Ogawa, 2017, International Journal of Hematology.

Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia Rescued with a Second Allogeneic Stem Cell Transplantation from a Haploidentical Mother after Relapse following Cord Blood Transplantation

S. Mineishi, H. Ogawa, H. Saji, 2004, International journal of hematology.

High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy

S. Hirota, S. Higasa, M. Okada, 2021, HemaSphere.

Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry

K. Ohta, J. Kanda, M. Hino, 2020, International Journal of Hematology.

Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.

J. Sakamoto, A. Ogata, I. Kawase, 2007, International journal of hematology.

Wilms Tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma

J. Sakamoto, A. Ogata, I. Kawase, 2007, International journal of hematology.

Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion

S. Hirota, M. Okada, S. Yoshihara, 2020, Annals of Hematology.

Solitary right ventricle metastasis by renal cell carcinoma.

I. Kawase, Y. Tomita, N. Hosen, 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan

S. Fujiwara, R. Yamazaki, T. Nagamura-Inoue, 2023, British journal of haematology.

Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation

H. Tamaki, T. Fujioka, T. Soma, 2013, International Journal of Hematology.

Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy

H. Tamaki, K. Ikegame, K. Kaida, 2023, Clinical Pharmacokinetics.

Molecular detection of AML1-MTG8-positive cells in peripheral blood from a patient with isolated extramedullary relapse of t(8;21) acute myeloid leukemia

H. Tamaki, M. Kawakami, T. Fujioka, 2009, Leukemia.

Measurable Residual Disease Assessment Using Next-Generation Flow in Patients With Relapsed and Refractory Multiple Myeloma Treated With a Combination of Carfilzomib, Lenalidomide, and Dexamethasone

K. Matsue, S. Yoshihara, M. Ueda, 2022, AntiCancer Research.

Individualized rabbit anti-thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high-risk hematologic malignancy: Exposure-response analysis and population pharmacokinetics simulations.

H. Tamaki, K. Ikegame, K. Kaida, 2024, American journal of hematology.